Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26814
Title: Sodium glucose-linked transport protein 2 inhibitors: An overview of genitourinary and perioperative implications.
Austin Authors: Chandrashekar, Mohit;Philip, Stuart;Nesbitt, Alexander;Joshi, Andre;Perera, Marlon 
Affiliation: Department of Urology, Western Health, The University of Melbourne, Melbourne, Victoria, Australia
School of Medicine, Griffith University, Gold Coast, Queensland, Australia
Surgery (University of Melbourne)
Department of Urology, Mater Hospital, Brisbane, Queensland, Australia
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
Issue Date: 22-Jun-2021
Date: 2021-06-22
Publication information: International Journal of Urology 2021; online first: 22 June
Abstract: Sodium glucose-linked transport protein 2 inhibitors are relatively novel drugs, used for the treatment of type 2 diabetes mellitus. Their use since Pharmaceutical Benefits Scheme approval in Australia has increased drastically, possibly due to the low risk of hypoglycemic events and their advertised cardiovascular mortality benefits. However, as with any novel drug, adverse effects regarding their use require medical practitioner awareness for optimal patient outcomes. This paper aims to cover the major urological implications, including those pertinent perioperatively, that concern this class of drugs. There is a clear risk of developing genital mycotic infections with the use of sodium glucose-linked transport protein 2 inhibitors, including serious infections such as Fournier's gangrene. Evidence for developing urinary tract infections has been mixed. Sodium glucose-linked transport protein 2 inhibitor-induced lower urinary tract symptoms may have impacts on quality of life via pollakiuria and nocturia, of which there are increased reports. Perioperative use increases the risk of euglycemic diabetic ketoacidosis. It is recommended that sodium glucose-linked transport protein 2 inhibitors be ceased perioperatively.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26814
DOI: 10.1111/iju.14624
Journal: International Journal of Urology
PubMed URL: 34155680
Type: Journal Article
Subjects: diabetic ketoacidosis
hypoglycemic agents
lower urinary tract symptoms
urinary bladder overactive
urinary tract infections
Appears in Collections:Journal articles

Show full item record

Page view(s)

18
checked on Apr 17, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.